Overview

Phentermine/Topiramate Extended Release in Binge Eating Disorder (BED)

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The goal of this project is to evaluate the effectiveness and tolerability of the novel weight management medication PHEN/TPM ER (Qsymia®)along with nutritional and lifestyle modification counseling in the treatment of binge eating disorder (BED) in overweight or obese individuals.
Phase:
Phase 2
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborator:
University of Cincinnati
Treatments:
Phentermine
Topiramate